Cti tracker

The Contraceptive Technology Innovation Tracker—CTI Tracker—houses information on potential contraceptive leads in early development, products in pre-clinical and clinical development, and products with single-country regulatory approval. The Tracker reports on both active development platforms and inactive R&D.

Contraceptive Pipeline Baseline Report ⬇ Export Database

For more information about contraceptive R&D, visit our partner databases

Show Filters
Inactive
Last updated: November 20, 2025
Origami Female Condom
  • User: Female
  • Hormonal: Non-Hormonal
  • Delivery Type: Barrier
  • Intended Duration: Pericoital
  • Development Stage: Phase II
  • Developer(s)/Researcher(s): Origami Healthcare Products, Inc., Strata Various Product Design
Inactive
Last updated: November 20, 2025
Non-Invasive Laser Vasectomy
  • User: Male
  • Hormonal: Non-Hormonal
  • Delivery Type: Vas Deferens
  • Intended Duration: Permanent
  • Development Stage: Pre-Clinical
  • Developer(s)/Researcher(s): University of North Carolina at Charlotte
Inactive
Last updated: November 20, 2025
MIV-150 + LNG ring

MZCL Combination IVR

  • User: Female
  • Hormonal: Hormonal
  • Delivery Type: Vaginal Ring
  • Intended Duration: Short-Acting
  • Development Stage: Pre-Clinical
  • Developer(s)/Researcher(s): Population Council, ProMed Pharma
Active
Last updated: November 20, 2025
Miudella®

VeraCept, Copper and Nitinol Intrauterine Device

  • User: Female
  • Hormonal: Non-Hormonal
  • Delivery Type: Intrauterine
  • Intended Duration: Long-Acting
  • Development Stage: Single-Country Approval
  • Developer(s)/Researcher(s): ContraMed, LLC, Sebela Women's Health
Active
Last updated: November 19, 2025
Iron IUD
  • User: Female
  • Hormonal: Non-Hormonal
  • Delivery Type: Intrauterine
  • Intended Duration: Long-Acting
  • Development Stage: Discovery & Early Development
  • Developer(s)/Researcher(s): Lakehead University, University of Western Ontario
Active
Last updated: November 19, 2025
Intratubular RISUG
  • User: Female
  • Hormonal: Non-Hormonal
  • Delivery Type: Fallopian Tube
  • Intended Duration: Permanent
  • Development Stage: Pre-Clinical
  • Developer(s)/Researcher(s): Indian Institute of Technology, Kharagpur University of Rajasthan
Inactive
Last updated: November 19, 2025
Intervas Device (NRIFP Beijing)
  • User: Male
  • Hormonal: Non-Hormonal
  • Delivery Type: Vas Deferens
  • Intended Duration: Permanent
  • Development Stage: Phase II
  • Developer(s)/Researcher(s): National Research Institute for Family Planning in Beijing
Inactive
Last updated: November 19, 2025
High Intensity Testicular Ultrasound
  • User: Male
  • Hormonal: Non-Hormonal
  • Delivery Type: Vas Deferens
  • Intended Duration: Permanent
  • Development Stage: Pre-Clinical
  • Developer(s)/Researcher(s): Vitality Medical Products, COSO
Active
Last updated: November 19, 2025
Gestodene-Loaded Dissolving Microneedles

GEST-Loaded DMNs

  • User: Female
  • Hormonal: Hormonal
  • Delivery Type: Intradermal
  • Intended Duration: Short-Acting
  • Development Stage: Discovery & Early Development
  • Developer(s)/Researcher(s): China National Research Institute for Family Planning, Chinese Academy of Sciences
Active
Last updated: November 19, 2025
Frameless Magnetic IUD

3D-001

  • User: Female
  • Hormonal: Non-Hormonal
  • Delivery Type: Intrauterine
  • Intended Duration: Long-Acting
  • Development Stage: Pre-Clinical
  • Developer(s)/Researcher(s): 3Daughters